Latest Breaking News On - Lucie larguier - Page 7 : comparemela.com

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalNew yorkTransgene euronextLucie larguierCorporate communicationsInvestor access forumGlobal healthcare conferenceAccess forumTech innovation daysArtificial intelligenceRisk factorsUniversal registration document

Transgene Receives $15 3 Million from the Sale of Securities Held for Sale

Transgene Receives $15 3 Million from the Sale of Securities Held for Sale
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Transgene euronextSylvie berrebiLucie larguierCorporate communicationsRegulatory newsEuronext parisArtificial intelligenceRisk factorsUniversal registration documentDie experten

Transgene Receives $15 3 Million from the Sale of Securities Held for Sale

Transgene Receives $15 3 Million from the Sale of Securities Held for Sale
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Lucie larguierTransgene euronextCorporate communicationsRegulatory newsEuronext parisArtificial intelligenceRisk factorsUniversal registration document

Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023

New immunological data assessed by tetramer staining confirms the induction of T cell responses in treated patients All trial patients treated with TG4050 monotherapy continue to remain in remission

Mecklenburg vorpommernUnited kingdomUnited statesJoseph jasperStefan klotterInstitut curieMasamitsu kitaseTransgene euronextJean pierre delordSylvie berrebiAlexandra martinezLe tourneauChristophe le tourneauAlessandro rivaLucie larguierYujie zhao

Transgene Presents Immunological Data Demonstrating that TG4001, a Novel Therapeutic Cancer Vaccine,

TG4001 can induce de novo immune responses against HPV16 antigens E6 and E7 in patients with advanced HPV16-positive anogenital cancersPatients with complete objective response showed strong vaccine-induced immunoreactivityTransgene is preparing for a potentially registrational studySTRASBOURG, France (BUSINESS WIR.

United statesTransgene euronextAlessandro rivaLucie larguierCorporate communicationsAmerican society of clinical oncologyRegulatory newsEuronext parisAmerican societyClinical oncologyAnnual meetingArtificial intelligenceRisk factorsUniversal registration document